Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7715505

Concept 2018-04-01 to
2018-12-31
2018-10-01 to
2018-12-31
As at
2018-12-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
Key financial data of group
Business results of group
Revenue
1,005,028,000,000 JPY
357,932,000,000 JPY
1,300,316,000,000 JPY
999,443,000,000 JPY
359,690,000,000 JPY
Profit (loss) before tax
212,828,000,000 JPY
218,113,000,000 JPY
184,605,000,000 JPY
Profit (loss), attributable to owners of parent
191,535,000,000 JPY
87,669,000,000 JPY
164,679,000,000 JPY
142,614,000,000 JPY
60,497,000,000 JPY
Comprehensive income, attributable to owners of parent
196,167,000,000 JPY
198,539,000,000 JPY
237,115,000,000 JPY
Equity attributable to owners of parent
1,292,209,000,000 JPY
1,268,289,000,000 JPY
1,366,864,000,000 JPY
Total assets
1,928,325,000,000 JPY
1,858,205,000,000 JPY
1,933,831,000,000 JPY
Basic earnings (loss) per share
98.63
45.64
81.11
69.84
30.00
Diluted earnings (loss) per share
98.53
81.02
69.76
Ratio of owners' equity to gross assets
0.670 xbrli:pure
0.683 xbrli:pure
0.707 xbrli:pure
Cash flows from (used in) operating activities
203,681,000,000 JPY
312,614,000,000 JPY
215,340,000,000 JPY
Cash flows from (used in) investing activities
-28,461,000,000 JPY
-121,799,000,000 JPY
-93,832,000,000 JPY
Cash flows from (used in) financing activities
-173,340,000,000 JPY
-203,429,000,000 JPY
-143,097,000,000 JPY
Cash and cash equivalents
331,296,000,000 JPY
331,731,000,000 JPY
331,683,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.